Spontaneous remission (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Spontaneous remission" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
low place
low place
1,523rd place
976th place
269th place
201st place

doi.org

  • Hobohm, U. (2001). "Fever and cancer in perspective". Cancer Immunology, Immunotherapy. 50 (8): 391–6. doi:10.1007/s002620100216. PMC 11032960. PMID 11726133. S2CID 109998.
  • Zahl, P. H.; Maehlen, J.; Welch, H. G. (2008). "The natural history of invasive breast cancers detected by screening mammography". Archives of Internal Medicine. 168 (21): 2311–6. doi:10.1001/archinte.168.21.2311. PMID 19029493.
  • Challis, G. B.; Stam, H. J. (1990). "The spontaneous regression of cancer. A review of cases from 1900 to 1987". Acta Oncologica. 29 (5): 545–50. doi:10.3109/02841869009090048. PMID 2206563.
  • Hobohm, U. (2005). "Fever therapy revisited". British Journal of Cancer. 92 (3): 421–5. doi:10.1038/sj.bjc.6602386. PMC 2362074. PMID 15700041.
  • Hobohm, U.; Stanford, J. L.; Grange, J. M. (2008). "Pathogen-associated molecular pattern in cancer immunotherapy". Critical Reviews in Immunology. 28 (2): 95–107. doi:10.1615/critrevimmunol.v28.i2.10. PMID 18540826.
  • Maletzki, C.; Linnebacher, M.; Savai, R.; Hobohm, U. (2013). "Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy" (PDF). Cancer Immunology, Immunotherapy. 62 (8): 1283–92. doi:10.1007/s00262-013-1455-1. PMC 11028761. PMID 23832140. S2CID 26031460.
  • Rohdenburg, G. L. (1 April 1918). "Fluctuations in the Growth Energy of Malignant Tumors in Man, with Especial Reference to Spontaneous Recession". The Journal of Cancer Research. 3 (2): 193–225. doi:10.1158/jcr.1918.193 (inactive 12 July 2025).{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)

escholarship.org

fevertherapy.eu

newsweek.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Hobohm, U. (2001). "Fever and cancer in perspective". Cancer Immunology, Immunotherapy. 50 (8): 391–6. doi:10.1007/s002620100216. PMC 11032960. PMID 11726133. S2CID 109998.
  • Zahl, P. H.; Maehlen, J.; Welch, H. G. (2008). "The natural history of invasive breast cancers detected by screening mammography". Archives of Internal Medicine. 168 (21): 2311–6. doi:10.1001/archinte.168.21.2311. PMID 19029493.
  • Challis, G. B.; Stam, H. J. (1990). "The spontaneous regression of cancer. A review of cases from 1900 to 1987". Acta Oncologica. 29 (5): 545–50. doi:10.3109/02841869009090048. PMID 2206563.
  • Hobohm, U. (2005). "Fever therapy revisited". British Journal of Cancer. 92 (3): 421–5. doi:10.1038/sj.bjc.6602386. PMC 2362074. PMID 15700041.
  • Hobohm, U.; Stanford, J. L.; Grange, J. M. (2008). "Pathogen-associated molecular pattern in cancer immunotherapy". Critical Reviews in Immunology. 28 (2): 95–107. doi:10.1615/critrevimmunol.v28.i2.10. PMID 18540826.
  • Maletzki, C.; Linnebacher, M.; Savai, R.; Hobohm, U. (2013). "Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy" (PDF). Cancer Immunology, Immunotherapy. 62 (8): 1283–92. doi:10.1007/s00262-013-1455-1. PMC 11028761. PMID 23832140. S2CID 26031460.
  • Fauvet, J.; Roujeau, J.; Piet, R. (1964). "Spontaneous Cancer Cures and Regressions". La Revue du Praticien. 14: 2177–80. PMID 14157391.
  • Cole, W. H. (1976). "Spontaneous regression of cancer and the importance of finding its cause". National Cancer Institute Monograph. 44: 5–9. PMID 799760.

ncbi.nlm.nih.gov

  • Hobohm, U. (2001). "Fever and cancer in perspective". Cancer Immunology, Immunotherapy. 50 (8): 391–6. doi:10.1007/s002620100216. PMC 11032960. PMID 11726133. S2CID 109998.
  • Hobohm, U. (2005). "Fever therapy revisited". British Journal of Cancer. 92 (3): 421–5. doi:10.1038/sj.bjc.6602386. PMC 2362074. PMID 15700041.
  • Maletzki, C.; Linnebacher, M.; Savai, R.; Hobohm, U. (2013). "Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy" (PDF). Cancer Immunology, Immunotherapy. 62 (8): 1283–92. doi:10.1007/s00262-013-1455-1. PMC 11028761. PMID 23832140. S2CID 26031460.

semanticscholar.org

api.semanticscholar.org

  • Hobohm, U. (2001). "Fever and cancer in perspective". Cancer Immunology, Immunotherapy. 50 (8): 391–6. doi:10.1007/s002620100216. PMC 11032960. PMID 11726133. S2CID 109998.
  • Maletzki, C.; Linnebacher, M.; Savai, R.; Hobohm, U. (2013). "Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy" (PDF). Cancer Immunology, Immunotherapy. 62 (8): 1283–92. doi:10.1007/s00262-013-1455-1. PMC 11028761. PMID 23832140. S2CID 26031460.